My experience with Toleranzia AB has been nothing short of incredible! 😊 The products are amazing and the customer service is top-notch. I'm a very happy customer!
Questions about Toleranzia AB
What is Toleranzia AB?
Toleranzia AB is a biopharmaceutical company based in Stockholm, Sweden, that develops drugs to treat autoimmune orphan diseases. Their lead drug candidate, TOL2, specifically targets myasthenia gravis, an autoimmune nerve and muscle disease. The company's approach aims to cure or greatly alleviate the disease by targeting the underlying cause rather than just reducing symptoms. As of August 2025, Toleranzia's operations and assets were transferred to Flerie AB during a completed merger.
What is the Trustburn rating and review history for Toleranzia AB?
The Trustburn rating for Toleranzia AB is 4.3 out of 5 stars, based on 8 customer reviews posted between February 2023 and November 2023. The rating split shows a strong majority of 5-star reviews, with several 4-star and 3-star ratings also present. This feedback highlights a generally positive reception from customers who have interacted with the company's products and services.
What do reviewers consistently praise about Toleranzia AB?
Multiple reviewers on Trustburn praise the outstanding quality of the products and the top-notch customer service provided by Toleranzia AB. Customers frequently mention that the staff is friendly, helpful, and provides excellent support throughout the purchasing process. The consistent theme across reviews is a high level of satisfaction with both the product performance and the overall customer experience.
Where is Toleranzia AB located and what is its current corporate structure?
Toleranzia AB is located in Stockholm, Sweden, and operates as a subsidiary of Flerie AB (publ) following a completed merger in August 2025. The company's headquarters remain in Stockholm, and it functions as a helägt dotterbolag (wholly-owned subsidiary) within the Flerie group structure. The merger involved transferring all assets and liabilities to Flerie Invest AB and subsequently to Goldcup 37076 AB before the final name change.
What major corporate change occurred involving Toleranzia AB in 2025?
The merger between Flerie AB and Toleranzia AB was finalized on August 19, 2025, with legal effect granted on the same day. Shareholders received their fusion compensation around August 22, 2025, with no actions required on their part to receive the new Flerie shares. The transaction involved a specific exchange rate where 88 Toleranzia shares were converted into 1 new Flerie share for individual shareholders.
What does the official website say about the recent merger?
The company's website, toleranzia.se, states that their fusion with Flerie is complete and that the combined entity retains the name Flerie AB (publ). The website also directs users to www.flerie.com for further information regarding the merger and the new operational structure. This official communication confirms the integration of Toleranzia's business into the larger Flerie organization.
When did the merger between Flerie and Toleranzia officially conclude?
According to the company's own website, the fusion between Flerie and Toleranzia was completed on August 19, 2025. The combined company continues to operate from Stockholm under the Flerie AB (publ) name. The website explicitly states that the merger has received final legal effect and that Toleranzia's operations have been fully integrated into the new structure.
How can I contact Toleranzia AB?
You can reach Toleranzia AB by e-mail at info@toleranzia.com.
AI-generated from reviews on this page. Verify anything important with the company directly.
Toleranzia AB is an amazing company to work with. The products they offer are of great quality and their customer service is top-notch. I'm very satisfied with my purchase.
I recently purchased a product from Toleranzia AB and I must say, I am very impressed. The quality of the product exceeded my expectations and the customer service was excellent. I would highly recommend them to others.
I absolutely love the products from Toleranzia AB! 😊 The quality is outstanding and the customer service is excellent. Highly recommended!
I had a pleasant experience with Toleranzia AB. The staff was very helpful and provided great customer service. I highly recommend their products.
The products offered by this company are of great quality. I am satisfied with my purchase and would definitely buy from them again.
I had a great experience with this company. The staff was friendly and helpful throughout the entire process. The product I purchased was exactly what I was looking for. I would definitely shop here again!
Toleranzia AB is simply amazing! 😊 Their products are top-notch and the customer service is fantastic. I couldn't be happier with my experience.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Toleranzia AB
Toleranzia develops drugs that utilize the immune system's own intrinsic power to treat autoimmune orphan diseases. The drugs, which target the disease cause, can cure or greatly alleviate the disease and not just reduce the symptoms that current treatments do. The company's drug candidate, TOL2, is developed for the autoimmune nerve and muscle disease myasthenia gravis.
- Website
- toleranzia.se
- info@toleranzia.com